PRSS48
Serine protease 48
Also known as: ESSPL, PRS48_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q7RTY5
- Gene
- PRSS48
- Ensembl
- ENSG00000189099
- Chromosome
- 4
- Canonical length
- 328 aa
- Protein class
- Enzymes, Predicted membrane proteins, Predicted secreted proteins
- Secretome location
- Secreted - unknown location
OverviewNCBI Gene
Predicted to enable serine-type endopeptidase activity. Predicted to be involved in proteolysis. Predicted to be located in extracellular region. Predicted to be active in extracellular space. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
328 residues, UniProt reviewed canonical sequence.
>Q7RTY5|PRSS48
1 MGPAGCAFTL LLLLGISVCG QPVYSSRVVG GQDAAAGRWP WQVSLHFDHN FICGGSLVSE
61 RLILTAAHCI QPTWTTFSYT VWLGSITVGD SRKRVKYYVS KIVIHPKYQD TTADVALLKL
121 SSQVTFTSAI LPICLPSVTK QLAIPPFCWV TGWGKVKESS DRDYHSALQE AEVPIIDRQA
181 CEQLYNPIGI FLPALEPVIK EDKICAGDTQ NMKDSCKGDS GGPLSCHIDG VWIQTGVVSW
241 GLECGKSLPG VYTNVIYYQK WINATISRAN NLDFSDFLFP IVLLSLALLR PSCAFGPNTI
301 HRVGTVAEAV ACIQGWEENA WRFSPRGRLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PRSS48 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.32
- Highest tissue expression
- 0.6 nTPM
Expression across tissuesHPA
Tissue
- choroid plexus: 0.6 nTPM
- testis: 0.6 nTPM
- skin: 0.3 nTPM
- basal ganglia: 0.2 nTPM
- amygdala: 0.1 nTPM
- cerebral cortex: 0.1 nTPM
Single-cell type
- cardiomyocytes: 174 nCPM
- paneth cells: 50 nCPM
- myonuclei: 48 nCPM
- epicardial cells: 46 nCPM
- tuft cells: 35 nCPM
- salivary myoepithelial cells: 34 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- choroid plexus: 37 nTPM
- pons: 10 nTPM
- hypothalamus: 9.5 nTPM
- medulla oblongata: 9.1 nTPM
- cerebellum: 8.9 nTPM
- basal ganglia: 8.2 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.83
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.68
- DepMap mean gene effect
- 0.18
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PRSS48 as an antibody target. Whether an autoantibody or antibody against PRSS48 could matter depends on whether native PRSS48 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PRSS48 is annotated as secreted, so native PRSS48 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label PRSS48 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...